RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Clinical trials for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-in-Human trial launches for aggressive leukemia patients out of options
Disease control Recruiting nowThis is the first human study of an experimental drug called BL-M11D1 for adults with acute myeloid leukemia (AML) that has returned or stopped responding to standard treatments. The main goal is to find a safe dose and see how the body processes the drug, while also checking for…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hope for leukemia patients out of options
Disease control Recruiting nowThis early-stage study is testing a new oral drug called NMS-03597812 for adults with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. The main goals are to find a safe dose and see if the drug can help put the cancer into remission. The st…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC